Douglas C. Rice's Insider Trades & SAST Disclosures
Douglas C. Rice's most recent trade in Mimedx Group Inc was a trade of 45,929 Common Stock done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Douglas C. Rice.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 45,929 | 200,773 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 36,486 | 201,241 | - | - | Stock Options | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.79 per share. | 08 Jul 2024 | 12,749 | 147,929 (0%) | 0% | 6.8 | 86,566 | Common Stock |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 70,755 | 164,755 | - | - | Stock Options | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 58,478 | 160,678 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 97,200 | 97,200 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 94,000 | 94,000 | - | - | Stock Options | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 14,937 | 107,679 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 1,317 | 93,490 (0%) | 0% | 33.0 | 43,514 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 867 | 94,807 (0%) | 0% | 33.0 | 28,646 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 385 | 93,105 (0%) | 0% | 33.0 | 12,720 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 363 | 92,742 (0%) | 0% | 33.0 | 11,994 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 22,131 | 22,131 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 22,131 | 95,674 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Purchase of securities on an exchange or from another person at price $ 30.05 per share. | 19 Nov 2021 | 1,400 | 73,543 (0%) | 0% | 30.1 | 42,070 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.48 per share. | 03 Jul 2021 | 373 | 70,370 (0%) | 0% | 40.5 | 15,099 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 13,394 | 13,394 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 13,394 | 71,122 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 3,029 | 67,708 (0%) | 0% | 42.9 | 130,035 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 867 | 66,841 (0%) | 0% | 42.9 | 37,220 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 385 | 70,737 (0%) | 0% | 42.9 | 16,528 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 363 | 66,478 (0%) | 0% | 42.9 | 15,584 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.34 per share. | 08 Jul 2020 | 1,456 | 55,706 (0%) | 0% | 30.3 | 44,175 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.34 per share. | 01 Jul 2020 | 377 | 57,535 (0%) | 0% | 32.3 | 12,192 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.19 per share. | 01 Jul 2020 | 373 | 57,162 (0%) | 0% | 32.2 | 12,007 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 12,058 | 12,058 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 28,223 | 28,223 | - | - | Stock Option (right to buy) | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 8,816 | 55,999 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.09 per share. | 01 Apr 2020 | 381 | 47,183 (0%) | 0% | 26.1 | 9,940 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.66 per share. | 01 Apr 2020 | 363 | 55,636 (0%) | 0% | 26.7 | 9,678 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges